It's starting to seem like we agressively discuss a lot of proposed European rules here on HN. But, when they come into effect they're immediately ignored by the people who should be complying and the people who should be enforcing.
In this instance it might be because there are is no penalty for running afoul of the obligations:
> Updated laws on clinical trials that are not expected to become legally binding until 2020 specify that there should be penalties for institutions that don’t comply with the rules.
If following the rules was a mandatory requirement for further funding for the same institution, I am sure they would update their internal policies in an eyeblink.
